Actively Recruiting
Self-Acupressure for Primary Dysmenorrhea and Premenstrual Symptoms
Led by Nigde Omer Halisdemir University · Updated on 2026-02-18
120
Participants Needed
1
Research Sites
25 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This randomized, sham-controlled trial aims to evaluate the effects of self-administered acupressure on menstrual pain severity and premenstrual symptoms in women aged 18-30 years with primary dysmenorrhea. Participants will be randomly assigned to either a self-acupressure intervention group or a sham self-acupressure control group. The intervention will be applied during the premenstrual and menstrual periods over approximately six months. The primary outcome is the change in menstrual pain severity, and secondary outcomes include changes in premenstrual symptom severity, analgesic use, and menstruation-related activity limitation.
CONDITIONS
Official Title
Self-Acupressure for Primary Dysmenorrhea and Premenstrual Symptoms
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Female participants aged 18 to 30 years
- Regular menstrual cycles (21-35 days)
- Diagnosis of primary dysmenorrhea with moderate to severe menstrual pain
- Presence of premenstrual symptoms consistent with premenstrual syndrome
- Currently enrolled as a university student
- Willingness to perform self-acupressure as instructed for approximately six menstrual cycles
- Ability to understand the study procedures and provide written informed consent
You will not qualify if you...
- Secondary dysmenorrhea (e.g., endometriosis, uterine fibroids, pelvic inflammatory disease)
- Current use of hormonal contraceptives or hormonal therapy within the past 3 months
- Pregnancy or breastfeeding
- Chronic gynecological, endocrine, or systemic disease that may affect menstrual pain or symptoms
- Regular use of analgesic or anti-inflammatory medications outside menstruation
- Prior formal training or regular practice of acupuncture or acupressure
- Inability to comply with study procedures or follow-up schedule
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Niğde Ömer Halisdemir University Hospital
Niğde, Merkez, Turkey (Türkiye), 51240
Actively Recruiting
Research Team
P
Pınar Erdoğan, Assoc. Prof.
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
DOUBLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here